What does an FEV1/FVC ratio of 72% with FEV1 57% predicted and FVC 60% predicted indicate in an obese never‑smoker?

Mixed Ventilatory Pattern with Restrictive Component in an Obese Never-Smoker

This spirometry pattern indicates a mixed ventilatory defect—both obstruction and restriction—in an obese never-smoker, where the reduced FVC (60% predicted) is likely driven by obesity-related restrictive physiology rather than classic COPD. The FEV1/FVC ratio of 72% technically meets the traditional threshold for obstruction (< 70%), but this interpretation requires careful consideration in this clinical context 1.

Understanding the Spirometry Pattern

Your patient presents with:

• FEV1/FVC ratio: 72% (borderline obstruction by fixed ratio criteria)
• FEV1: 57% predicted (moderate impairment)
• FVC: 60% predicted (moderate reduction)

Why This Isn't Typical COPD

The absence of smoking history is critical here. COPD guidelines consistently define the disease in the context of noxious particle exposure, primarily cigarette smoke 1. In a never-smoker, alternative diagnoses must be vigorously pursued rather than defaulting to a COPD diagnosis.

The proportional reduction in both FEV1 and FVC suggests this is not pure obstruction. When FEV1/FVC is borderline and both volumes are reduced together, the pattern often reflects restriction with secondary effects on flow rates 2.

The Obesity Factor

Obesity significantly impacts spirometry interpretation in multiple ways:

• Restrictive physiology: Obesity mechanically restricts lung expansion, reducing FVC and total lung capacity 3, 4, 5
• Preserved FEV1/FVC ratio typically: Most obese subjects without lung disease maintain normal FEV1/FVC ratios despite reduced volumes 3, 4
• Fat-free mass matters: Increased muscle mass (fat-free mass) is actually associated with better lung function, while central adiposity and total body fat correlate inversely with FEV1 and FVC 5, 6

Research shows that obesity alone does not typically cause abnormal spirometry beyond reduced volumes 3. When an obese never-smoker shows a reduced FEV1/FVC ratio, this warrants investigation for alternative pathology rather than attribution to obesity alone.

Critical Next Steps

1. Confirm Mixed Pattern with Lung Volumes

You must measure total lung capacity (TLC) by body plethysmography to definitively diagnose a mixed defect 2. A mixed ventilatory defect is only confirmed when:

• FEV1/FVC < 5th percentile (obstruction present)
• AND TLC < 5th percentile (restriction confirmed)

Without TLC measurement, you cannot distinguish between:

• True mixed disease
• Obstruction with hyperinflation masquerading as reduced FVC
• Primary restriction with secondary flow limitation

2. Consider Alternative Diagnoses

In an obese never-smoker with this pattern, investigate:

• Small airways disease from occupational/environmental exposures
• Asthma (check bronchodilator response, consider methacholine challenge)
• Interstitial lung disease (obtain DLCO, high-resolution CT if DLCO reduced)
• Obesity hypoventilation syndrome (check arterial blood gases)
• Neuromuscular weakness (measure maximal inspiratory/expiratory pressures)
• Cardiac dysfunction contributing to reduced lung volumes

3. Assess Diffusing Capacity (DLCO)

DLCO measurement is essential to differentiate between emphysema, interstitial disease, and obesity-related restriction 1. Obesity typically preserves or even increases DLCO, while parenchymal lung disease reduces it.

Severity Classification Considerations

Using traditional COPD severity criteria, the FEV1 of 57% predicted would classify as moderate COPD (40-59% predicted) 1. However, this classification system was developed for smoking-related COPD and may not apply to your patient.

The FEV1/FVC ratio of 72% is borderline, particularly given:

• Older guidelines used < 70% as the obstruction threshold 1
• Newer evidence suggests this fixed ratio may overdiagnose obstruction in elderly patients 7, 8
• The 5th percentile (lower limit of normal) approach is more specific 2, 9

Common Pitfalls to Avoid

1. Don't diagnose COPD in a never-smoker without exhaustive alternative investigation—the absence of smoking history fundamentally changes the differential diagnosis

2. Don't attribute abnormal spirometry solely to obesity—research shows obesity doesn't typically cause obstruction 3

3. Don't rely on spirometry alone—lung volumes and DLCO are mandatory for proper classification 2

4. Don't use FEV1/FVC ratio to grade severity—absolute FEV1 predicts outcomes, not the ratio 1, 2

5. Don't assume the pattern is static—obtain bronchodilator response testing to assess reversibility 9

Clinical Implications for Morbidity and Mortality

The absolute FEV1 value (57% predicted) is the strongest predictor of mortality and disability, regardless of the underlying cause 1, 2. This level of impairment significantly impacts:

• Exercise tolerance and dyspnea
• Risk of respiratory failure
• Perioperative risk if surgery needed
• Overall mortality risk

The combination of obesity and reduced lung function creates compounded risk for cardiovascular disease and respiratory complications 5.

Your immediate priority is obtaining complete pulmonary function testing (including lung volumes and DLCO) and pursuing the correct diagnosis rather than empirically treating presumed COPD in this never-smoker.